Fernando Alegre

1.2k total citations · 1 hit paper
15 papers, 984 citations indexed

About

Fernando Alegre is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Fernando Alegre has authored 15 papers receiving a total of 984 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Infectious Diseases and 5 papers in Epidemiology. Recurrent topics in Fernando Alegre's work include HIV/AIDS drug development and treatment (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and HIV Research and Treatment (3 papers). Fernando Alegre is often cited by papers focused on HIV/AIDS drug development and treatment (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and HIV Research and Treatment (3 papers). Fernando Alegre collaborates with scholars based in Spain, United States and Italy. Fernando Alegre's co-authors include Pablo Pelegrı́n, Nadezda Apostolova, Juan V. Esplugues, Ana Blas‐García, Ariel E. Feldstein, Haryes A. Funes, Leon A. Adams, Alexander Wree, Tatiana Kisseleva and Hal M. Hoffman and has published in prestigious journals such as PLoS ONE, Gut and The Journal of Infectious Diseases.

In The Last Decade

Fernando Alegre

15 papers receiving 978 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis

2020 405 citations Susanne Gaul, Aleksandra Leszczynska et al. Journal of Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fernando Alegre Spain	12	470	422	270	133	132	15	984
Yedidya Saiman United States	14	767 1.6×	282 0.7×	798 3.0×	63 0.5×	72 0.5×	22	1.4k
Esperance Schaefer United States	20	518 1.1×	209 0.5×	398 1.5×	269 2.0×	40 0.3×	45	1.1k
S. Galastri Italy	13	426 0.9×	161 0.4×	334 1.2×	22 0.2×	28 0.2×	17	790
M Wettstein Germany	14	155 0.3×	204 0.5×	136 0.5×	47 0.4×	36 0.3×	27	728
Shan Liang China	15	179 0.4×	206 0.5×	40 0.1×	75 0.6×	118 0.9×	23	636
Miriam Ruth Bueno‐Topete Mexico	17	327 0.7×	263 0.6×	330 1.2×	62 0.5×	9 0.1×	45	870
C H Halsted United States	20	213 0.5×	222 0.5×	42 0.2×	34 0.3×	62 0.5×	33	1.1k
Mashiko Setshedi South Africa	14	441 0.9×	236 0.6×	112 0.4×	112 0.8×	6 0.0×	40	1.0k
Pavitra Keshavan United States	10	186 0.4×	254 0.6×	37 0.1×	87 0.7×	37 0.3×	15	614
Thomas Damgaard Sandahl Denmark	22	853 1.8×	208 0.5×	594 2.2×	51 0.4×	14 0.1×	79	1.5k

Countries citing papers authored by Fernando Alegre

Since Specialization

Citations

This map shows the geographic impact of Fernando Alegre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernando Alegre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernando Alegre more than expected).

Fields of papers citing papers by Fernando Alegre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fernando Alegre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernando Alegre. The network helps show where Fernando Alegre may publish in the future.

Co-authorship network of co-authors of Fernando Alegre

This figure shows the co-authorship network connecting the top 25 collaborators of Fernando Alegre. A scholar is included among the top collaborators of Fernando Alegre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fernando Alegre. Fernando Alegre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Alegre, Fernando, D Ortiz‐Masiá, Celia Bañuls, et al.. (2022). Macrophages Modulate Hepatic Injury Involving NLRP3 Inflammasome: The Example of Efavirenz. Biomedicines. 10(1). 109–109. 5 indexed citations

Gaul, Susanne, Aleksandra Leszczynska, Fernando Alegre, et al.. (2020). Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis. Journal of Hepatology. 74(1). 156–167. 405 indexed citations breakdown →

Alegre, Fernando, et al.. (2019). The interaction between RUNX2 and core binding factor beta as a potential therapeutic target in canine osteosarcoma. Veterinary and Comparative Oncology. 18(1). 52–63. 6 indexed citations

Alegre, Fernando, Francisco García‐García, Anabel Fernández‐Iglesias, et al.. (2019). Rilpivirine attenuates liver fibrosis through selective STAT1-mediated apoptosis in hepatic stellate cells. Gut. 69(5). 920–932. 92 indexed citations

Alegre, Fernando, et al.. (2018). A genetically engineered microRNA-34a prodrug demonstrates anti-tumor activity in a canine model of osteosarcoma. PLoS ONE. 13(12). e0209941–e0209941. 17 indexed citations

Alegre, Fernando, et al.. (2017). Role of p62/SQSTM1 beyond autophagy: a lesson learned from drug‐induced toxicity in vitro. British Journal of Pharmacology. 175(3). 440–455. 33 indexed citations

Alegre, Fernando, et al.. (2017). Lon protease: a novel mitochondrial matrix protein in the interconnection between drug‐induced mitochondrial dysfunction and endoplasmic reticulum stress. British Journal of Pharmacology. 174(23). 4409–4429. 31 indexed citations

Alegre, Fernando, Pablo Pelegrı́n, & Ariel E. Feldstein. (2017). Inflammasomes in Liver Fibrosis. Seminars in Liver Disease. 37(2). 119–127. 148 indexed citations

Blas‐García, Ana, Víctor M. Víctor, Fernando Alegre, et al.. (2016). The purine analogues abacavir and didanosine increase acetaminophen-induced hepatotoxicity by enhancing mitochondrial dysfunction. Journal of Antimicrobial Chemotherapy. 71(4). 916–926. 14 indexed citations

10.

Alegre, Fernando, Haryes A. Funes, Ana Blas‐García, et al.. (2014). Mitochondrial (dys)function – a factor underlying the variability of efavirenz‐induced hepatotoxicity?. British Journal of Pharmacology. 172(7). 1713–1727. 23 indexed citations

11.

Funes, Haryes A., Nadezda Apostolova, Fernando Alegre, et al.. (2014). Neuronal Bioenergetics and Acute Mitochondrial Dysfunction: A Clue to Understanding the Central Nervous System Side Effects of Efavirenz. The Journal of Infectious Diseases. 210(9). 1385–1395. 65 indexed citations

12.

Blas‐García, Ana, Fernando Alegre, Haryes A. Funes, et al.. (2014). Lack of mitochondrial toxicity of darunavir, raltegravir and rilpivirine in neurons and hepatocytes: a comparison with efavirenz. Journal of Antimicrobial Chemotherapy. 69(11). 2995–3000. 48 indexed citations

13.

Apostolova, Nadezda, et al.. (2014). Involvement of Nitric Oxide in the Mitochondrial Action of Efavirenz: A Differential Effect on Neurons and Glial Cells. The Journal of Infectious Diseases. 211(12). 1953–1958. 28 indexed citations

14.

Alegre, Fernando, et al.. (2013). 516 EFAVIRENZ INDUCES ENDOPLASMATIC STRESS IN HUMAN HEPATIC CELLS BY A MECHANISM DIFFERENT THAN THAT ELICITED BY THE PHARMACOLOGICAL INDUCER THAPSIGARGIN. Journal of Hepatology. 58. S212–S212. 1 indexed citations

15.

Apostolova, Nadezda, Fernando Alegre, Haryes A. Funes, et al.. (2013). ER stress in human hepatic cells treated with Efavirenz: Mitochondria again. Journal of Hepatology. 59(4). 780–789. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact